Home / About / Governance / Executive Committee

Executive Committee

The Executive Committee makes time-sensitive decisions in between Board meetings. The decisions are ratified at the next full Board meetings.

Members of the Committee

Karimah Es Sabar A highly-recognized Canadian life sciences leader, Karimah Es Sabar brought 30 years of dynamic global business experience to her role as President and CEO of The Centre for Drug Research and Development (CDRD) headquartered in Vancouver, British Columbia, Canada. She previously held the position of Senior Vice-President, Business and Strategic Affairs at CDRD, responsible for ensuring the organization’s long-term sustainability, while leading its business functions and successfully building the many national and international alliances and strategic partnerships which are now contributing significantly to advancing the goals of CDRD.

CEO and Partner,
Quark Venture Inc.
Joseph Garcia Joseph Garcia is a partner who practises in the areas of corporate finance and mergers & acquisitions at Blake, Cassels & Graydon LLP. Joseph advises high growth public and private companies, underwriters, pension funds, private equity groups, and venture capital investors on complex domestic and cross-border private and public securities offerings, mergers & acquisitions, and international commercial transactions. He advises clients in a variety of industries, including life sciences, technology, retail, mining and clean technology.

Partner,
Blake, Cassels & Graydon LLP
Nils Petersen
Dr. Petersen is a Fellow of the Chemical Institute of Canada. He currently serves as a member of three boards of not-for-profit organizations including Compute Canada, TECTERRA, and the Canadian Light Source (CLS) for which he is Chair of the Board. He recently finished terms as a member of the boards of ArboraNano, a Business-led NCE, the California Nanosystems Institute (CNSI), and the Pacific Institute for Mathematical Sciences, and as Chair of the Board of NSERC’s Strategic Network program BiopSys at the University of Toronto.

Professor Emeritus,
University of Alberta
Stewart Roth Stewart is a successful Edmonton businessman with broad experience in the chemical industry. He is the past Chair of the Alberta Hospital Edmonton Foundation, Director of Northeast Capital Industrial Association (NCIA), Chair of NCIA Education Committee, and a member of Synergy Networks in Edmonton.

President/CEO,
Guardian Chemicals Inc.
Warren Wakarchuk Dr. Wakarchuk is a Professor from the Department of Biological Sciences at the University of Alberta. The Wakarchuk lab investigates the structure and function of the enzymes which make and degrade various glycoconjugates. This work has been enabling the chemo-enzymatic synthesis of bioactive glycoconjugates both in the laboratory and for industrial projects. The Wakarchuk lab has expertise with both mammalian and bacterial carbohydrate active enzymes for glycan remodelling applications.
Scientific Director, GlycoNet

Observer

Elizabeth Nanak
Dr. Nanak is the Network’s Executive Director. Dr. Nanak was involved in the GlycoNet initiative since the Letter of Intent stage and served as the Associate Director, Business for the Alberta Glycomics Centre from 2007–2015. Prior to her position with the Centre, she worked as a manager of large-scale and multi-institutional projects with Genome Prairie. In addition to her PhD in biochemistry, Elizabeth has an MBA in biotechnology management.

Chief Executive Officer,
GlycoNet

© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.

en_USEnglish
Scroll to Top